GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Earnings per Share (Diluted)

Qilian International Holding Group (Qilian International Holding Group) Earnings per Share (Diluted) : $-0.22 (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Earnings per Share (Diluted)?

Qilian International Holding Group's Earnings per Share (Diluted) for the six months ended in Sep. 2023 was $-0.23. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.22.

Qilian International Holding Group's EPS (Basic) for the six months ended in Sep. 2023 was $-0.23. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.22.

Qilian International Holding Group's EPS without NRI for the six months ended in Sep. 2023 was $-0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.06.

During the past 12 months, Qilian International Holding Group's average EPS without NRIGrowth Rate was -308.00% per year.

During the past 7 years, Qilian International Holding Group's highest 3-Year average EPS without NRI Growth Rate was 52.90% per year. The lowest was -30.70% per year. And the median was -19.60% per year.


Qilian International Holding Group Earnings per Share (Diluted) Historical Data

The historical data trend for Qilian International Holding Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Earnings per Share (Diluted) Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Earnings per Share (Diluted)
Get a 7-Day Free Trial 0.15 0.15 0.09 0.03 -0.22

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - 0.03 0.01 -0.23

Competitive Comparison of Qilian International Holding Group's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's PE Ratio falls into.



Qilian International Holding Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Qilian International Holding Group's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (A: Sep. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.781-0)/35.750
=-0.22

Qilian International Holding Group's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (Q: Sep. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-8.276-0)/35.750
=-0.23

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Qilian International Holding Group  (NAS:QLI) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Qilian International Holding Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines